Study to Determine if Serum BNP Levels Are Elevated in Pregnant Women With Pre-Eclampsia
Utilization of Serum BNP to Distinguish Pre-Eclampsia From Hypertension in Pregnancy
1 other identifier
observational
61
1 country
1
Brief Summary
Preeclampsia is a common disease state occurring in the third trimester of pregnancy, with an incidence of approximately 5-10% in the US. Hypertension (high blood pressure), a primary symptom of pre-eclampsia, may be present in women who were hypertensive prior to becoming pregnant.B-type (also known as brain) natriuretic peptide (BNP) is known to be made and released from the heart ventricles when the heart is strained. There is also evidence that BNP is secreted in the placenta, and may increase in preeclampsia and chronic hypertension in pregnancy.The purpose of the study is to determine if a maternal blood sample analyzed for the quantity of BNP is helpful in differentiating between pre-eclampsia and chronic high blood pressure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2003
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2003
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 21, 2007
CompletedFirst Posted
Study publicly available on registry
September 24, 2007
CompletedSeptember 24, 2007
September 1, 2007
September 21, 2007
September 21, 2007
Conditions
Keywords
Study Arms (3)
Normotensive
Pregnant women in the third trimester with normal blood pressure this pregnancy and no history of HTN or pre-eclampsia in a previous pregnancy
Chronic Hypertensive
Pregnant women in their third trimester with known hypertension prior to the current pregnancy
Pre-eclampsia
Pregnant women in their third trimester who meet ACOG diagnostic criteria for pre-eclampsia
Eligibility Criteria
You may qualify if:
- Pregnant women age 18 or older at 34 or more weeks of pregnancy
- Control arm:normal blood pressure during pregnancy
- Chronic HTN arm: known to have HTN predating this gestation
- Pre-eclampsia arm:meet ACOG diagnostic criteria for pre-eclampsia this pregnancy and present to labor and delivery for evaluation and/ or treatment
You may not qualify if:
- minors, prisoners,unable to provide consent
- multiple gestation
- currently in labor
- Control arm:presence of hypertension, a history of gestational hypertension, current therapy with an anti-hypertensive medication, any history of congestive heart failure
- Chronic HTN arm:evidence of superimposed preeclampsia at the time of enrollment (headache, proteinuria, peripheral edema, or visual changes), any history of congestive heart failure
- Pre-eclampsia arm:history of congestive heart failure, pretreatment with anti-hypertensive medication
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Ohio State University
Columbus, Ohio, 43210, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Brian C Hiestand, MD
Ohio State University Department of Emergency Medicine
Study Design
- Study Type
- observational
- Observational Model
- DEFINED POPULATION
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 21, 2007
First Posted
September 24, 2007
Study Start
February 1, 2003
Study Completion
June 1, 2005
Last Updated
September 24, 2007
Record last verified: 2007-09